ReP USP - Resultado da busca

Artigo de periodico
A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor (2021)
Alencar, Stela Santos de; Crippa, José Alexandre de Souza ; Brito, Manuelina C. M.; Pimentel, Angela Vieira; Hallak, Jaime Eduardo Cecilio ; Tumas, Vitor
Source: Parkinsonism & Related Disorders. Unidade: FMRP
Subjects: CANABINOIDES, CANABINOIDES, TREMOR, MÉTODO DUPLO-CEGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALENCAR, Stela Santos de et al. A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor. Parkinsonism & Related Disorders, v. 83, p. 37-40, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.parkreldis.2021.01.001. Acesso em: 27 maio 2024.
APA
Alencar, S. S. de, Crippa, J. A. de S., Brito, M. C. M., Pimentel, A. V., Hallak, J. E. C., & Tumas, V. (2021). A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor. Parkinsonism & Related Disorders, 83, 37-40. doi:10.1016/j.parkreldis.2021.01.001
NLM
Alencar SS de, Crippa JA de S, Brito MCM, Pimentel AV, Hallak JEC, Tumas V. A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor [Internet]. Parkinsonism & Related Disorders. 2021 ; 83 37-40.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.parkreldis.2021.01.001
Vancouver
Alencar SS de, Crippa JA de S, Brito MCM, Pimentel AV, Hallak JEC, Tumas V. A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor [Internet]. Parkinsonism & Related Disorders. 2021 ; 83 37-40.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.parkreldis.2021.01.001
Artigo de periodico
Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial (2021)
Guimarães, Tiago Moraes; Guimarães, Mara R. C.; Oliveira, Ícaro A. F.; Leoni, Renata Ferranti ; Santos, Antonio Carlos dos ; Dursun, Serdar M.; Crippa, José Alexandre de Souza ; Bressan, Rodrigo A.; Machado-de-Sousa, João Paulo ; Lacerda, Acioly L. T.; Hallak, Jaime Eduardo Cecilio
Source: Journal of Clinical Psychopharmacology. Unidades: FFCLRP, FMRP
Subjects: ANTIPSICÓTICOS, MÉTODO DUPLO-CEGO, FARMACOTERAPIA, ESQUIZOFRENIA, RESULTADO DE TRATAMENTO, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Tiago Moraes et al. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial. Journal of Clinical Psychopharmacology, v. 41, n. 3, p. 260-266, 2021Tradução . . Disponível em: https://doi.org/10.1097/JCP.0000000000001388. Acesso em: 27 maio 2024.
APA
Guimarães, T. M., Guimarães, M. R. C., Oliveira, Í. A. F., Leoni, R. F., Santos, A. C. dos, Dursun, S. M., et al. (2021). Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial. Journal of Clinical Psychopharmacology, 41( 3), 260-266. doi:10.1097/JCP.0000000000001388
NLM
Guimarães TM, Guimarães MRC, Oliveira ÍAF, Leoni RF, Santos AC dos, Dursun SM, Crippa JA de S, Bressan RA, Machado-de-Sousa JP, Lacerda ALT, Hallak JEC. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 260-266.[citado 2024 maio 27 ] Available from: https://doi.org/10.1097/JCP.0000000000001388
Vancouver
Guimarães TM, Guimarães MRC, Oliveira ÍAF, Leoni RF, Santos AC dos, Dursun SM, Crippa JA de S, Bressan RA, Machado-de-Sousa JP, Lacerda ALT, Hallak JEC. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 260-266.[citado 2024 maio 27 ] Available from: https://doi.org/10.1097/JCP.0000000000001388
Artigo de periodico
Cortical surface abnormalities are different depending on the stage of schizophrenia: a cross-sectional vertexwise mega-analysis of thickness, area and gyrification (2021)
Rosa, Pedro Gomes Penteado; Zugman, Andre; Cerqueira, Carlos Toledo; Serpa, Mauricio Henriques ; Duran, Fábio Luís de Souza; Zanetti, Marcus Vinicius; Bassitt, Débora Pastore; Elkis, Helio ; Crippa, José Alexandre de Souza ; Sallet, Paulo Clemente; Gattaz, Wagner Farid ; Hallak, Jaime Eduardo Cecilio ; Louzã Neto, Mario Rodrigues; Gadelha, Ary; Jackowski, Andrea Parolin; Bressan, Rodrigo Affonseca; Busatto Filho, Geraldo
Source: Schizophrenia Research. Unidades: FM, FMRP
Subjects: TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, ANTIPSICÓTICOS, CÓRTEX CEREBRAL, DIAGNÓSTICO POR IMAGEM, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSA, Pedro Gomes Penteado et al. Cortical surface abnormalities are different depending on the stage of schizophrenia: a cross-sectional vertexwise mega-analysis of thickness, area and gyrification. Schizophrenia Research, v. 236, p. 104-114, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2021.08.011. Acesso em: 27 maio 2024.
APA
Rosa, P. G. P., Zugman, A., Cerqueira, C. T., Serpa, M. H., Duran, F. L. de S., Zanetti, M. V., et al. (2021). Cortical surface abnormalities are different depending on the stage of schizophrenia: a cross-sectional vertexwise mega-analysis of thickness, area and gyrification. Schizophrenia Research, 236, 104-114. doi:10.1016/j.schres.2021.08.011
NLM
Rosa PGP, Zugman A, Cerqueira CT, Serpa MH, Duran FL de S, Zanetti MV, Bassitt DP, Elkis H, Crippa JA de S, Sallet PC, Gattaz WF, Hallak JEC, Louzã Neto MR, Gadelha A, Jackowski AP, Bressan RA, Busatto Filho G. Cortical surface abnormalities are different depending on the stage of schizophrenia: a cross-sectional vertexwise mega-analysis of thickness, area and gyrification [Internet]. Schizophrenia Research. 2021 ; 236 104-114.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.schres.2021.08.011
Vancouver
Rosa PGP, Zugman A, Cerqueira CT, Serpa MH, Duran FL de S, Zanetti MV, Bassitt DP, Elkis H, Crippa JA de S, Sallet PC, Gattaz WF, Hallak JEC, Louzã Neto MR, Gadelha A, Jackowski AP, Bressan RA, Busatto Filho G. Cortical surface abnormalities are different depending on the stage of schizophrenia: a cross-sectional vertexwise mega-analysis of thickness, area and gyrification [Internet]. Schizophrenia Research. 2021 ; 236 104-114.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.schres.2021.08.011
Artigo de periodico
Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors (2021)
Pereira, Anamaria Falcão; Lisboa, Mario Roberto Pontes; Alves, Bruno Wesley de Freitas; Silva, Cristiane Maria Pereira da; Dias, Diego Bernarde Souza; Menezes, Karoline Luanne Santos; Cesário, Francisco Rafael Alves Santana; França, Jonas Costa de; Oliveira, Amanda Rocha de; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza ; Alencar, Nylane Maria Nunes de; Lima Júnior, Roberto Cesar Pereira; Vale, Mariana Lima
Source: Neurotoxicity Research. Unidade: FMRP
Subjects: GÂNGLIOS ESPINHAIS, NOCICEPTIVIDADE, ANTINEOPLÁSICOS, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Anamaria Falcão et al. Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors. Neurotoxicity Research, v. 39, n. 6, p. 1782-1799, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12640-021-00442-x. Acesso em: 27 maio 2024.
APA
Pereira, A. F., Lisboa, M. R. P., Alves, B. W. de F., Silva, C. M. P. da, Dias, D. B. S., Menezes, K. L. S., et al. (2021). Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors. Neurotoxicity Research, 39( 6), 1782-1799. doi:10.1007/s12640-021-00442-x
NLM
Pereira AF, Lisboa MRP, Alves BW de F, Silva CMP da, Dias DBS, Menezes KLS, Cesário FRAS, França JC de, Oliveira AR de, Hallak JEC, Zuardi AW, Crippa JA de S, Alencar NMN de, Lima Júnior RCP, Vale ML. Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors [Internet]. Neurotoxicity Research. 2021 ; 39( 6): 1782-1799.[citado 2024 maio 27 ] Available from: https://doi.org/10.1007/s12640-021-00442-x
Vancouver
Pereira AF, Lisboa MRP, Alves BW de F, Silva CMP da, Dias DBS, Menezes KLS, Cesário FRAS, França JC de, Oliveira AR de, Hallak JEC, Zuardi AW, Crippa JA de S, Alencar NMN de, Lima Júnior RCP, Vale ML. Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors [Internet]. Neurotoxicity Research. 2021 ; 39( 6): 1782-1799.[citado 2024 maio 27 ] Available from: https://doi.org/10.1007/s12640-021-00442-x
Artigo de periodico
Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum (2021)
Pedrazzi, João Francisco Cordeiro; Sales, Amanda Juliana; Guimarães, Francisco Silveira ; Joca, Sâmia Regiane Lourenço ; Crippa, José Alexandre de Souza ; Del Bel, Elaine Aparecida
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FMRP, FCFRP, FORP
Subjects: ANFETAMINAS, ANTIPSICÓTICOS, COMPORTAMENTO ANIMAL, CANABINOIDES, METILAÇÃO DE DNA, CÓRTEX PRÉ-FRONTAL, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 111, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2021.110352. Acesso em: 27 maio 2024.
APA
Pedrazzi, J. F. C., Sales, A. J., Guimarães, F. S., Joca, S. R. L., Crippa, J. A. de S., & Del Bel, E. A. (2021). Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 111. doi:10.1016/j.pnpbp.2021.110352
NLM
Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JA de S, Del Bel EA. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110352
Vancouver
Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JA de S, Del Bel EA. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110352
Artigo de periodico-carta/editorial
Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] (2021)
Pacheco, Júlia Cozar; Souza, José Diogo dos Santos; Hallak, Jaime Eduardo Cecilio ; Osório, Flávia de Lima ; Campos, Alline Cristina de; Guimarães, Francisco Silveira ; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza
Source: Journal of Clinical Psychopharmacology. Unidade: FMRP
Subjects: CANABINOIDES, ANTICONVULSIVANTES, COVID-19, ESTRESSE PROFISSIONAL, SAÚDE MENTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PACHECO, Júlia Cozar et al. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/JCP.0000000000001405. Acesso em: 27 maio 2024. , 2021
APA
Pacheco, J. C., Souza, J. D. dos S., Hallak, J. E. C., Osório, F. de L., Campos, A. C. de, Guimarães, F. S., et al. (2021). Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1097/JCP.0000000000001405
NLM
Pacheco JC, Souza JD dos S, Hallak JEC, Osório F de L, Campos AC de, Guimarães FS, Zuardi AW, Crippa JA de S. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 327-329.[citado 2024 maio 27 ] Available from: https://doi.org/10.1097/JCP.0000000000001405
Vancouver
Pacheco JC, Souza JD dos S, Hallak JEC, Osório F de L, Campos AC de, Guimarães FS, Zuardi AW, Crippa JA de S. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 327-329.[citado 2024 maio 27 ] Available from: https://doi.org/10.1097/JCP.0000000000001405
Artigo de periodico
Cannabidiol induces autophagy via ERK1/2 activation in neural cells (2021)
Vrechi, Talita Aparecida de Moraes; Leão, Anderson H. F. F.; Morais, Ingrid B. M.; Abilio, Vanessa Costhek; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Bincoletto, Cláudia; Ureshino, Rodrigo P.; Smaili, Soraya Soubhi; Pereira, Gustavo José da Silva
Source: Scientific Reports. Unidade: FMRP
Subjects: CANABINOIDES, LINHAGEM CELULAR, DOENÇAS NEURODEGENERATIVAS, NEUROBLASTOMA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VRECHI, Talita Aparecida de Moraes et al. Cannabidiol induces autophagy via ERK1/2 activation in neural cells. Scientific Reports, v. 11, n. 1, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41598-021-84879-2. Acesso em: 27 maio 2024.
APA
Vrechi, T. A. de M., Leão, A. H. F. F., Morais, I. B. M., Abilio, V. C., Zuardi, A. W., Hallak, J. E. C., et al. (2021). Cannabidiol induces autophagy via ERK1/2 activation in neural cells. Scientific Reports, 11( 1). doi:10.1038/s41598-021-84879-2
NLM
Vrechi TA de M, Leão AHFF, Morais IBM, Abilio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Ureshino RP, Smaili SS, Pereira GJ da S. Cannabidiol induces autophagy via ERK1/2 activation in neural cells [Internet]. Scientific Reports. 2021 ; 11( 1):[citado 2024 maio 27 ] Available from: https://doi.org/10.1038/s41598-021-84879-2
Vancouver
Vrechi TA de M, Leão AHFF, Morais IBM, Abilio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Ureshino RP, Smaili SS, Pereira GJ da S. Cannabidiol induces autophagy via ERK1/2 activation in neural cells [Internet]. Scientific Reports. 2021 ; 11( 1):[citado 2024 maio 27 ] Available from: https://doi.org/10.1038/s41598-021-84879-2
Artigo de periodico
Efficacy and safety of cannabidiol plus standard care vs standard care alone for the treatment of emotional exhaustion and Burnout among frontline health care workers during the COVID-19 pandemic: a randomized clinical trial (2021)
Crippa, José Alexandre de Souza ; Zuardi, Antonio Waldo; Guimarães, Francisco Silveira ; Campos, Alline Cristina de; Osório, Flávia de Lima ; Loureiro, Sonia Regina ; Santos, Rafael Guimarães dos ; Souza, José Diogo dos Santos; Ushirohira, Juliana Mayumi; Pacheco, Júlia Cozar; Ferreira, Rafael Rinaldi; Costa, Karla Cristinne Mancini ; Scomparin, Davi Silveira; Scarante, Franciele Franco ; Santos, Isabela Pires dos; Mechoulam, Raphael; Kapczinski, Flávio; Fonseca, Benedito Antonio Lopes da; Esposito, Danillo Lucas Alves ; Lima, Karina Pereira; Sen, Srijan; Andraus, Maristela Haddad; Hallak, Jaime Eduardo Cecilio
Source: JAMA Network Open. Unidade: FMRP
Subjects: CANABINOIDES, ANSIOLÍTICOS, ESTRESSE PROFISSIONAL, EQUIPE DE ASSISTÊNCIA AO PACIENTE, COVID-19, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Efficacy and safety of cannabidiol plus standard care vs standard care alone for the treatment of emotional exhaustion and Burnout among frontline health care workers during the COVID-19 pandemic: a randomized clinical trial. JAMA Network Open, v. 4, n. 8, 2021Tradução . . Disponível em: https://doi.org/10.1001/jamanetworkopen.2021.20603. Acesso em: 27 maio 2024.
APA
Crippa, J. A. de S., Zuardi, A. W., Guimarães, F. S., Campos, A. C. de, Osório, F. de L., Loureiro, S. R., et al. (2021). Efficacy and safety of cannabidiol plus standard care vs standard care alone for the treatment of emotional exhaustion and Burnout among frontline health care workers during the COVID-19 pandemic: a randomized clinical trial. JAMA Network Open, 4( 8). doi:10.1001/jamanetworkopen.2021.20603
NLM
Crippa JA de S, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Loureiro SR, Santos RG dos, Souza JD dos S, Ushirohira JM, Pacheco JC, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Lima KP, Sen S, Andraus MH, Hallak JEC. Efficacy and safety of cannabidiol plus standard care vs standard care alone for the treatment of emotional exhaustion and Burnout among frontline health care workers during the COVID-19 pandemic: a randomized clinical trial [Internet]. JAMA Network Open. 2021 ; 4( 8):[citado 2024 maio 27 ] Available from: https://doi.org/10.1001/jamanetworkopen.2021.20603
Vancouver
Crippa JA de S, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Loureiro SR, Santos RG dos, Souza JD dos S, Ushirohira JM, Pacheco JC, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Lima KP, Sen S, Andraus MH, Hallak JEC. Efficacy and safety of cannabidiol plus standard care vs standard care alone for the treatment of emotional exhaustion and Burnout among frontline health care workers during the COVID-19 pandemic: a randomized clinical trial [Internet]. JAMA Network Open. 2021 ; 4( 8):[citado 2024 maio 27 ] Available from: https://doi.org/10.1001/jamanetworkopen.2021.20603
Artigo de periodico
Risk and protective factors for the mental health of Brazilian healthcare workers in the frontline of COVID-19 pandemic (2021)
Osório, Flávia de Lima ; Silveira, Isabella Lara Machado ; Lima, Karina Pereira; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Loureiro, Sonia Regina
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: SAÚDE MENTAL, FATORES DE RISCO, COVID-19, PANDEMIAS, TRABALHADORES, SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OSÓRIO, Flávia de Lima et al. Risk and protective factors for the mental health of Brazilian healthcare workers in the frontline of COVID-19 pandemic. Frontiers in Psychiatry, v. 12, 2021Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2021.662742. Acesso em: 27 maio 2024.
APA
Osório, F. de L., Silveira, I. L. M., Lima, K. P., Crippa, J. A. de S., Hallak, J. E. C., Zuardi, A. W., & Loureiro, S. R. (2021). Risk and protective factors for the mental health of Brazilian healthcare workers in the frontline of COVID-19 pandemic. Frontiers in Psychiatry, 12. doi:10.3389/fpsyt.2021.662742
NLM
Osório F de L, Silveira ILM, Lima KP, Crippa JA de S, Hallak JEC, Zuardi AW, Loureiro SR. Risk and protective factors for the mental health of Brazilian healthcare workers in the frontline of COVID-19 pandemic [Internet]. Frontiers in Psychiatry. 2021 ; 12[citado 2024 maio 27 ] Available from: https://doi.org/10.3389/fpsyt.2021.662742
Vancouver
Osório F de L, Silveira ILM, Lima KP, Crippa JA de S, Hallak JEC, Zuardi AW, Loureiro SR. Risk and protective factors for the mental health of Brazilian healthcare workers in the frontline of COVID-19 pandemic [Internet]. Frontiers in Psychiatry. 2021 ; 12[citado 2024 maio 27 ] Available from: https://doi.org/10.3389/fpsyt.2021.662742
Artigo de periodico
Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13 (2021)
Falvella, Ana Caroline Brambilla; Smith, Bradley Joseph; Silva-Costa, Licia C.; Valença, Aline G. F.; Crunfli, Fernanda; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Almeida, Valéria de; Martins-de Souza, Daniel
Source: Frontiers in Molecular Neuroscience. Unidade: FMRP
Subjects: ESQUIZOFRENIA, ANTIPSICÓTICOS, LINHAGEM CELULAR, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FALVELLA, Ana Caroline Brambilla et al. Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13. Frontiers in Molecular Neuroscience, v. 14, 2021Tradução . . Disponível em: https://doi.org/10.3389/fnmol.2021.673144. Acesso em: 27 maio 2024.
APA
Falvella, A. C. B., Smith, B. J., Silva-Costa, L. C., Valença, A. G. F., Crunfli, F., Zuardi, A. W., et al. (2021). Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13. Frontiers in Molecular Neuroscience, 14. doi:10.3389/fnmol.2021.673144
NLM
Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JEC, Crippa JA de S, Almeida V de, Martins-de Souza D. Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13 [Internet]. Frontiers in Molecular Neuroscience. 2021 ; 14[citado 2024 maio 27 ] Available from: https://doi.org/10.3389/fnmol.2021.673144
Vancouver
Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JEC, Crippa JA de S, Almeida V de, Martins-de Souza D. Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13 [Internet]. Frontiers in Molecular Neuroscience. 2021 ; 14[citado 2024 maio 27 ] Available from: https://doi.org/10.3389/fnmol.2021.673144
Artigo de periodico
Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? (2021)
Loss, Cássio Morais; Teodoro, Lucas; Rodrigues, Gabriela Doná; Moreira, Lucas Roberto; Peres, Fernanda Fiel; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Abilio, Vanessa Costhek
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, TRANSTORNO AUTÍSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOSS, Cássio Morais et al. Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders?. Frontiers in Pharmacology, v. 11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.635763. Acesso em: 27 maio 2024.
APA
Loss, C. M., Teodoro, L., Rodrigues, G. D., Moreira, L. R., Peres, F. F., Zuardi, A. W., et al. (2021). Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? Frontiers in Pharmacology, 11. doi:10.3389/fphar.2020.635763
NLM
Loss CM, Teodoro L, Rodrigues GD, Moreira LR, Peres FF, Zuardi AW, Crippa JA de S, Hallak JEC, Abilio VC. Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? [Internet]. Frontiers in Pharmacology. 2021 ; 11[citado 2024 maio 27 ] Available from: https://doi.org/10.3389/fphar.2020.635763
Vancouver
Loss CM, Teodoro L, Rodrigues GD, Moreira LR, Peres FF, Zuardi AW, Crippa JA de S, Hallak JEC, Abilio VC. Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? [Internet]. Frontiers in Pharmacology. 2021 ; 11[citado 2024 maio 27 ] Available from: https://doi.org/10.3389/fphar.2020.635763
Artigo de periodico-carta/editorial
Cannabinoids for the treatment of mental disorders [Carta] (2020)
Crippa, José Alexandre de Souza ; Osório, Flávia de Lima ; Hallak, Jaime Eduardo Cecilio ; Guimarães, Francisco Silveira ; Zuardi, Antonio Waldo
Source: The Lancet Psychiatry. Unidade: FMRP
Subjects: CANABINOIDES, ARTIGO CIENTÍFICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabinoids for the treatment of mental disorders [Carta]. The Lancet Psychiatry. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S2215-0366(19)30516-4. Acesso em: 27 maio 2024. , 2020
APA
Crippa, J. A. de S., Osório, F. de L., Hallak, J. E. C., Guimarães, F. S., & Zuardi, A. W. (2020). Cannabinoids for the treatment of mental disorders [Carta]. The Lancet Psychiatry. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/S2215-0366(19)30516-4
NLM
Crippa JA de S, Osório F de L, Hallak JEC, Guimarães FS, Zuardi AW. Cannabinoids for the treatment of mental disorders [Carta] [Internet]. The Lancet Psychiatry. 2020 ; 7( 2): 125-126.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/S2215-0366(19)30516-4
Vancouver
Crippa JA de S, Osório F de L, Hallak JEC, Guimarães FS, Zuardi AW. Cannabinoids for the treatment of mental disorders [Carta] [Internet]. The Lancet Psychiatry. 2020 ; 7( 2): 125-126.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/S2215-0366(19)30516-4
Artigo de periodico
Effects of acute cannabidiol administration on anxiety and tremors induced by a simulated public speaking test in patients with Parkinson's disease (2020)
Faria, Stephanie Martins de ; Fabrício, Daiene de Morais ; Tumas, Vitor ; Castro, Paula Costa ; Ponti, Moacir Antonelli ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antônio Waldo ; Crippa, José Alexandre de Souza ; Chagas, Marcos Hortes Nisihara
Source: Journal of Psychopharmacology. Unidades: FMRP, ICMC
Subjects: CANABINOIDES, DOENÇA DE PARKINSON, ANSIEDADE, TREMOR, PROCESSAMENTO DE SINAIS, TECNOLOGIAS DA SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIA, Stephanie Martins de et al. Effects of acute cannabidiol administration on anxiety and tremors induced by a simulated public speaking test in patients with Parkinson's disease. Journal of Psychopharmacology, v. 34, n. 2, 2020Tradução . . Disponível em: https://doi.org/10.1177/0269881119895536. Acesso em: 27 maio 2024.
APA
Faria, S. M. de, Fabrício, D. de M., Tumas, V., Castro, P. C., Ponti, M. A., Hallak, J. E. C., et al. (2020). Effects of acute cannabidiol administration on anxiety and tremors induced by a simulated public speaking test in patients with Parkinson's disease. Journal of Psychopharmacology, 34( 2). doi:10.1177/0269881119895536
NLM
Faria SM de, Fabrício D de M, Tumas V, Castro PC, Ponti MA, Hallak JEC, Zuardi AW, Crippa JA de S, Chagas MHN. Effects of acute cannabidiol administration on anxiety and tremors induced by a simulated public speaking test in patients with Parkinson's disease [Internet]. Journal of Psychopharmacology. 2020 ; 34( 2):[citado 2024 maio 27 ] Available from: https://doi.org/10.1177/0269881119895536
Vancouver
Faria SM de, Fabrício D de M, Tumas V, Castro PC, Ponti MA, Hallak JEC, Zuardi AW, Crippa JA de S, Chagas MHN. Effects of acute cannabidiol administration on anxiety and tremors induced by a simulated public speaking test in patients with Parkinson's disease [Internet]. Journal of Psychopharmacology. 2020 ; 34( 2):[citado 2024 maio 27 ] Available from: https://doi.org/10.1177/0269881119895536
Artigo de periodico-dep/entr
Prof. Elisaldo Araújo Carlini, cannabis and cannabinoids research pioneer (June 9, 1930–September 16, 2020) [Depoimento] (2020)
Zuardi, Antonio Waldo; Takahashi, Reinaldo Naoto; Guimarães, Francisco Silveira ; Crippa, José Alexandre de Souza
Source: Cannabis and Cannabinoid Research. Unidade: FMRP
Subjects: CANABINOIDES, CANNABIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUARDI, Antonio Waldo et al. Prof. Elisaldo Araújo Carlini, cannabis and cannabinoids research pioneer (June 9, 1930–September 16, 2020) [Depoimento]. Cannabis and Cannabinoid Research. New Rochelle: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1089/can.2020.0121. Acesso em: 27 maio 2024. , 2020
APA
Zuardi, A. W., Takahashi, R. N., Guimarães, F. S., & Crippa, J. A. de S. (2020). Prof. Elisaldo Araújo Carlini, cannabis and cannabinoids research pioneer (June 9, 1930–September 16, 2020) [Depoimento]. Cannabis and Cannabinoid Research. New Rochelle: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1089/can.2020.0121
NLM
Zuardi AW, Takahashi RN, Guimarães FS, Crippa JA de S. Prof. Elisaldo Araújo Carlini, cannabis and cannabinoids research pioneer (June 9, 1930–September 16, 2020) [Depoimento] [Internet]. Cannabis and Cannabinoid Research. 2020 ; 5( 4): 272-273.[citado 2024 maio 27 ] Available from: https://doi.org/10.1089/can.2020.0121
Vancouver
Zuardi AW, Takahashi RN, Guimarães FS, Crippa JA de S. Prof. Elisaldo Araújo Carlini, cannabis and cannabinoids research pioneer (June 9, 1930–September 16, 2020) [Depoimento] [Internet]. Cannabis and Cannabinoid Research. 2020 ; 5( 4): 272-273.[citado 2024 maio 27 ] Available from: https://doi.org/10.1089/can.2020.0121
Artigo de periodico
In-tube solid-phase microextraction with a dummy molecularly imprinted monolithic capillary coupled to ultra-performance liquid chromatography-tandem mass spectrometry to determine cannabinoids in plasma samples (2020)
Marchioni, Camila; Vieira, Tatiana Manzini ; Crotti, Antonio Eduardo Miller ; Crippa, José Alexandre de Souza ; Queiroz, Maria Eugênia Costa
Source: Analytica Chimica Acta. Unidades: FFCLRP, FMRP
Subjects: CANABINOIDES, PLASMA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCHIONI, Camila et al. In-tube solid-phase microextraction with a dummy molecularly imprinted monolithic capillary coupled to ultra-performance liquid chromatography-tandem mass spectrometry to determine cannabinoids in plasma samples. Analytica Chimica Acta, v. 1099, p. 145-154, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.aca.2019.11.017. Acesso em: 27 maio 2024.
APA
Marchioni, C., Vieira, T. M., Crotti, A. E. M., Crippa, J. A. de S., & Queiroz, M. E. C. (2020). In-tube solid-phase microextraction with a dummy molecularly imprinted monolithic capillary coupled to ultra-performance liquid chromatography-tandem mass spectrometry to determine cannabinoids in plasma samples. Analytica Chimica Acta, 1099, 145-154. doi:10.1016/j.aca.2019.11.017
NLM
Marchioni C, Vieira TM, Crotti AEM, Crippa JA de S, Queiroz MEC. In-tube solid-phase microextraction with a dummy molecularly imprinted monolithic capillary coupled to ultra-performance liquid chromatography-tandem mass spectrometry to determine cannabinoids in plasma samples [Internet]. Analytica Chimica Acta. 2020 ; 1099 145-154.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.aca.2019.11.017
Vancouver
Marchioni C, Vieira TM, Crotti AEM, Crippa JA de S, Queiroz MEC. In-tube solid-phase microextraction with a dummy molecularly imprinted monolithic capillary coupled to ultra-performance liquid chromatography-tandem mass spectrometry to determine cannabinoids in plasma samples [Internet]. Analytica Chimica Acta. 2020 ; 1099 145-154.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.aca.2019.11.017
Artigo de periodico
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials (2020)
Santos, Rafael Guimarães dos ; Guimarães, Francisco Silveira ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Rossi, Giordano Novak; Rocha, Juliana Mendes; Zuardi, Antonio Waldo
Source: Expert Opinion on Drug Metabolism & Toxicology. Unidade: FMRP
Subjects: CANABINOIDES, INTERAÇÃO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials. Expert Opinion on Drug Metabolism & Toxicology, v. 16, n. 6, p. 517-526, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425255.2020.1754793. Acesso em: 27 maio 2024.
APA
Santos, R. G. dos, Guimarães, F. S., Crippa, J. A. de S., Hallak, J. E. C., Rossi, G. N., Rocha, J. M., & Zuardi, A. W. (2020). Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials. Expert Opinion on Drug Metabolism & Toxicology, 16( 6), 517-526. doi:10.1080/17425255.2020.1754793
NLM
Santos RG dos, Guimarães FS, Crippa JA de S, Hallak JEC, Rossi GN, Rocha JM, Zuardi AW. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2020 ; 16( 6): 517-526.[citado 2024 maio 27 ] Available from: https://doi.org/10.1080/17425255.2020.1754793
Vancouver
Santos RG dos, Guimarães FS, Crippa JA de S, Hallak JEC, Rossi GN, Rocha JM, Zuardi AW. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2020 ; 16( 6): 517-526.[citado 2024 maio 27 ] Available from: https://doi.org/10.1080/17425255.2020.1754793
Artigo de periodico
Oral cannabidiol does not convert to Δ8-THC or Δ9-THC in humans: a pharmacokinetic study in healthy subjects (2020)
Crippa, José Alexandre de Souza ; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio ; Miyazawa, Bruna; Bernardo, Sandra Aparecida; Donaduzzi, Carmen Maria; Guzzi, Silvane; Favreto, Wagner Alex Jann ; Campos, Alline Cristina de ; Queiroz, Maria Eugênia Costa ; Guimarães, Francisco Silveira ; Zimmermann, Patrícia Moura da Rosa; Rechia, Letícia Mello; Tondo Filho, Volnei José; Brum Júnior, Liberato
Source: Cannabis and Cannabinoid Research. Unidades: FMRP, FFCLRP
Subjects: CANABINOIDES, FARMACOCINÉTICA, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Oral cannabidiol does not convert to Δ8-THC or Δ9-THC in humans: a pharmacokinetic study in healthy subjects. Cannabis and Cannabinoid Research, v. 5, n. 1, p. 89-98, 2020Tradução . . Disponível em: https://doi.org/10.1089/can.2019.0024. Acesso em: 27 maio 2024.
APA
Crippa, J. A. de S., Zuardi, A. W., Hallak, J. E. C., Miyazawa, B., Bernardo, S. A., Donaduzzi, C. M., et al. (2020). Oral cannabidiol does not convert to Δ8-THC or Δ9-THC in humans: a pharmacokinetic study in healthy subjects. Cannabis and Cannabinoid Research, 5( 1), 89-98. doi:10.1089/can.2019.0024
NLM
Crippa JA de S, Zuardi AW, Hallak JEC, Miyazawa B, Bernardo SA, Donaduzzi CM, Guzzi S, Favreto WAJ, Campos AC de, Queiroz MEC, Guimarães FS, Zimmermann PM da R, Rechia LM, Tondo Filho VJ, Brum Júnior L. Oral cannabidiol does not convert to Δ8-THC or Δ9-THC in humans: a pharmacokinetic study in healthy subjects [Internet]. Cannabis and Cannabinoid Research. 2020 ; 5( 1): 89-98.[citado 2024 maio 27 ] Available from: https://doi.org/10.1089/can.2019.0024
Vancouver
Crippa JA de S, Zuardi AW, Hallak JEC, Miyazawa B, Bernardo SA, Donaduzzi CM, Guzzi S, Favreto WAJ, Campos AC de, Queiroz MEC, Guimarães FS, Zimmermann PM da R, Rechia LM, Tondo Filho VJ, Brum Júnior L. Oral cannabidiol does not convert to Δ8-THC or Δ9-THC in humans: a pharmacokinetic study in healthy subjects [Internet]. Cannabis and Cannabinoid Research. 2020 ; 5( 1): 89-98.[citado 2024 maio 27 ] Available from: https://doi.org/10.1089/can.2019.0024
Artigo de periodico
Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias (2020)
Marchioni, Camila; Santos-Lobato, Bruno Lopes; Queiroz, Maria Eugênia Costa ; Crippa, José Alexandre de Souza ; Tumas, Vitor
Source: Journal of Neural Transmission. Unidades: FFCLRP, FMRP, FCFRP
Subjects: DOENÇA DE PARKINSON, DISCINESIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCHIONI, Camila et al. Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias. Journal of Neural Transmission, v. 127, n. 10, p. 1359-1367, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00702-020-02240-9. Acesso em: 27 maio 2024.
APA
Marchioni, C., Santos-Lobato, B. L., Queiroz, M. E. C., Crippa, J. A. de S., & Tumas, V. (2020). Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias. Journal of Neural Transmission, 127( 10), 1359-1367. doi:10.1007/s00702-020-02240-9
NLM
Marchioni C, Santos-Lobato BL, Queiroz MEC, Crippa JA de S, Tumas V. Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias [Internet]. Journal of Neural Transmission. 2020 ; 127( 10): 1359-1367.[citado 2024 maio 27 ] Available from: https://doi.org/10.1007/s00702-020-02240-9
Vancouver
Marchioni C, Santos-Lobato BL, Queiroz MEC, Crippa JA de S, Tumas V. Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias [Internet]. Journal of Neural Transmission. 2020 ; 127( 10): 1359-1367.[citado 2024 maio 27 ] Available from: https://doi.org/10.1007/s00702-020-02240-9
Artigo de periodico
Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus (2020)
Khan, Asmat Ullah; Falconi-Sobrinho, Luiz Luciano ; Anjos-Garcia, Tayllon dos ; Sampaio, Maria de Fátima dos Santos; Crippa, José Alexandre de Souza ; Menescal-de-Oliveira, Leda; Coimbra, Norberto Cysne
Source: Psychopharmacology. Unidade: FMRP
Subjects: MEDO, PÂNICO, CANABINOIDES, ANTAGONISTAS, COMPOSTOS ORGÂNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KHAN, Asmat Ullah et al. Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus. Psychopharmacology, v. 237, n. 4, p. 1063-1079, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00213-019-05435-5. Acesso em: 27 maio 2024.
APA
Khan, A. U., Falconi-Sobrinho, L. L., Anjos-Garcia, T. dos, Sampaio, M. de F. dos S., Crippa, J. A. de S., Menescal-de-Oliveira, L., & Coimbra, N. C. (2020). Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus. Psychopharmacology, 237( 4), 1063-1079. doi:10.1007/s00213-019-05435-5
NLM
Khan AU, Falconi-Sobrinho LL, Anjos-Garcia T dos, Sampaio M de F dos S, Crippa JA de S, Menescal-de-Oliveira L, Coimbra NC. Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus [Internet]. Psychopharmacology. 2020 ; 237( 4): 1063-1079.[citado 2024 maio 27 ] Available from: https://doi.org/10.1007/s00213-019-05435-5
Vancouver
Khan AU, Falconi-Sobrinho LL, Anjos-Garcia T dos, Sampaio M de F dos S, Crippa JA de S, Menescal-de-Oliveira L, Coimbra NC. Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus [Internet]. Psychopharmacology. 2020 ; 237( 4): 1063-1079.[citado 2024 maio 27 ] Available from: https://doi.org/10.1007/s00213-019-05435-5
Artigo de periodico
Proneness, urbanicity, trauma, and cannabis triggering psychotic states in large urban centers (2020)
Machado-de-Sousa, João Paulo ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio
Source: Current Opinion in Psychiatry. Unidade: FMRP
Subjects: PSIQUIATRIA, TRANSTORNOS PSICÓTICOS, URBANIZAÇÃO, MACONHA, DROGAS DE ABUSO, ESQUIZOFRENIA, TRAUMA EMOCIONAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO-DE-SOUSA, João Paulo e CRIPPA, José Alexandre de Souza e HALLAK, Jaime Eduardo Cecilio. Proneness, urbanicity, trauma, and cannabis triggering psychotic states in large urban centers. Current Opinion in Psychiatry, v. 33, n. 3, p. 250-254, 2020Tradução . . Disponível em: https://doi.org/10.1097/YCO.0000000000000592. Acesso em: 27 maio 2024.
APA
Machado-de-Sousa, J. P., Crippa, J. A. de S., & Hallak, J. E. C. (2020). Proneness, urbanicity, trauma, and cannabis triggering psychotic states in large urban centers. Current Opinion in Psychiatry, 33( 3), 250-254. doi:10.1097/YCO.0000000000000592
NLM
Machado-de-Sousa JP, Crippa JA de S, Hallak JEC. Proneness, urbanicity, trauma, and cannabis triggering psychotic states in large urban centers [Internet]. Current Opinion in Psychiatry. 2020 ; 33( 3): 250-254.[citado 2024 maio 27 ] Available from: https://doi.org/10.1097/YCO.0000000000000592
Vancouver
Machado-de-Sousa JP, Crippa JA de S, Hallak JEC. Proneness, urbanicity, trauma, and cannabis triggering psychotic states in large urban centers [Internet]. Current Opinion in Psychiatry. 2020 ; 33( 3): 250-254.[citado 2024 maio 27 ] Available from: https://doi.org/10.1097/YCO.0000000000000592

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration